By a News Reporter-Staff News TECFIDERA was first approved in the United States "TECFIDERA exemplifies our commitment to deliver innovative therapies that help people living with serious diseases," said George A. Scangos The EC approval is ... 4 Traders, 3 weeks ago
Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Revision: 0, Authorised - European Medicines Agency, 1 week ago
First-line oral treatment for Multiple Sclerosis approved by EU - PrimaryCare Today, 1 month ago
1 images for "Tecfidera Treated Patients"
Health Canada Approves New Strength For TECFIDERA(TM), A First-Line Oral Treatment For Multiple Sclerosis
TECFIDERA now available as 240 mg delayed-release capsules MISSISSAUGA, ON, Feb. 18, 2014 /CNW/ - Today, Biogen Idec Canada announces the Health Canada approval of TECFIDERA (dimethyl fumarate) 240 mg strength capsule, a first-line oral treatment ...Canada NewsWire, 2 weeks ago
Patients with relapsing-remitting multiple sclerosis now have a further oral treatment option available: dimethyl fumarate. This is the second medicine for this form of MS to be launched this year, after teriflunomide was made available last month. ...PJ Online, 1 month ago The changing fortunes of dimethyl fumarate Hospital Pharmacy Europe, 3 weeks ago
Biogen Idec's oral multiple sclerosis drug Tecfidera has won approval in Europe as a first-line treatment for people with relapsing-remitting multiple sclerosis (RRMS). Tipped as a blockbuster in waiting, the European Commission's expected green ...Pharmafocus, 1 month ago Biogen wins European approval for new MS drug CNBC, 1 month ago
The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen's Tecfidera has revolutionised multiple sclerosis treatment in the U.S., eroding significant market share from older therapies. However, patent ...Yahoo! Finance, 1 month ago Can you feel it? Neurology treatments moving forward Pharmacist.com, 1 month ago New treatment options for Multiple Sclerosis Hospital News, 3 weeks ago An Option On Adoption Of A New Multiple Sclerosis Treatment Seeking Alpha, 1 month ago
NICE have said theyre minded to say no to allowing the new oral MS drug dimethyl fumarate (Tecfidera) to be freely available on the NHS in England and Wales for people with relapsing remitting MS . The drug was licensed earlier this month to ...Multiple Sclerosis Society, 2 weeks ago Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision Multiple Sclerosis Trust, 2 weeks ago NICE says initial 'no' to MS drug BootsWebMD, 2 weeks ago NICE approval for Sanofi's MS tablet Pharma Field, 1 month ago
A new oral medicine, known as dimethyl fumarate (or Tecfidera), has been licensed to treat people with relapsing remitting MS in Europe. This means the treatment which is taken twice a day has been viewed as safe and effective by regulatory ...Multiple Sclerosis Society, 1 month ago
Summary Tcelna has the opportunity to provide patients with a first in line therapy for Secondary Progressive Multiple Sclerosis that is not toxic. Opexa investors that remain long term have the ability to reap huge rewards if the phase 2b trial ...Seeking Alpha, 10 hours ago
Biogen Idec (BIIB: Quote), which develops therapies to treat neurodegenerative diseases, hemophilia and autoimmune disorders, Thursday announced signing an agreement to grant UCB, a biopharmaceutical company focused on treatments for diseases of the ...RTTNews.com, 1 month ago Biogen Idec 4Q results beat analysts' estimates CNBC, 1 month ago
BIOGEN IDEC INC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
In the near term, our revenues are dependent upon continued sales of our four principal products, AVONEX, TYSABRI, TECFIDERA and RITUXAN. In the longer term, our revenue growth will be dependent upon the successful clinical development, regulatory ...TMC Net, 1 month ago
on your WebpageAdd Widget >Get your members hooked!